Targeting microglial PPARα ameliorates the outcome of ischemic stroke by enhancing interaction with infiltrating

Tong Ren1, Maoshu Zhu2, Xilin Jiang1

  • 1Xiamen Cardiovascular Hospital of Xiamen University, Fujian Branch of National Clinical Research Center for Cardiovascular Diseases, School of Medicine, Xiamen University, Xiamen 361002, P.R. China.

Cell Reports
|June 21, 2025
PubMed

Insights

Microglial peroxisome proliferator-activated receptor-alpha (PPARα) downregulation exacerbates ischemic stroke by promoting inflammatory cell infiltration. Targeting microglial PPARα offers a potential therapeutic strategy for acute cerebral ischemic injury.

Area of Science:

  • Neuroscience
  • Immunology
  • Cell Biology

Background:

  • Immune cell interactions with brain cells drive inflammation in ischemic stroke.
  • The specific role of microglia in modulating infiltrating monocytes/macrophages after stroke is unclear.

Purpose of the Study:

  • Investigate the role of microglial peroxisome proliferator-activated receptor-alpha (PPARα) in acute ischemic stroke (AIS).
  • Elucidate the molecular mechanisms by which microglia influence peripheral immune cell infiltration and brain injury.

Main Methods:

  • Studied ischemia-induced changes in microglial PPARα expression in an AIS model.
  • Investigated the impact of microglial PPARα modulation on immune cell infiltration and blood-brain barrier (BBB) integrity.
  • Examined the effects of microglia-specific PPARα overexpression on neuroprotection and immune cell crosstalk.

Main Results:

  • Ischemia downregulated microglial PPARα, enhancing inflammation and exacerbating brain injury.
  • Targeting microglial PPARα protected the BBB and reduced innate immune cell infiltration.
  • Overexpressing microglial PPARα promoted neuroprotection via IL-4 signaling-mediated microglia-macrophage crosstalk.

Conclusions:

  • Ischemia-induced microglial PPARα deficiency worsens stroke outcomes by increasing peripheral immune cell interaction.
  • Microglial PPARα is a potential therapeutic target for acute ischemic stroke.